86 related articles for article (PubMed ID: 19090781)
1. Systematic research of peptide spacers controlling drug release from macromolecular prodrug system, carboxymethyldextran polyalcohol-peptide-drug conjugates.
Shiose Y; Kuga H; Ohki H; Ikeda M; Yamashita F; Hashida M
Bioconjug Chem; 2009 Jan; 20(1):60-70. PubMed ID: 19090781
[TBL] [Abstract][Full Text] [Related]
2. Hyperthermia-enhanced tumor accumulation and antitumor efficacy of a doxorubicin-conjugate with a novel macromolecular carrier system in mice with non-small cell lung cancer.
Oyama T; Kawamura M; Abiko T; Izumi Y; Watanabe M; Kumazawa E; Kuga H; Shiose Y; Kobayashi K
Oncol Rep; 2007 Mar; 17(3):653-9. PubMed ID: 17273747
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of carboxymethylpullulan-peptide-doxorubicin conjugates and their properties.
Nogusa H; Yano T; Okuno S; Hamana H; Inoue K
Chem Pharm Bull (Tokyo); 1995 Nov; 43(11):1931-6. PubMed ID: 8575033
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effects and toxicities of carboxymethylpullulan-peptide-doxorubicin conjugates.
Nogusa H; Yano T; Kajiki M; Gonsho A; Hamana H; Okuno S
Biol Pharm Bull; 1997 Oct; 20(10):1061-5. PubMed ID: 9353565
[TBL] [Abstract][Full Text] [Related]
5. Distribution characteristics of carboxymethylpullulan-peptide-doxorubicin conjugates in tumor-bearing rats: different sequence of peptide spacers and doxorubicin contents.
Nogusa H; Yamamoto K; Yano T; Kajiki M; Hamana H; Okuno S
Biol Pharm Bull; 2000 May; 23(5):621-6. PubMed ID: 10823676
[TBL] [Abstract][Full Text] [Related]
6. Controlled release of free doxorubicin from peptide-drug conjugates by drug loading.
Chen Z; Zhang P; Cheetham AG; Moon JH; Moxley JW; Lin YA; Cui H
J Control Release; 2014 Oct; 191():123-30. PubMed ID: 24892976
[TBL] [Abstract][Full Text] [Related]
7. Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates.
Andersson L; Davies J; Duncan R; Ferruti P; Ford J; Kneller S; Mendichi R; Pasut G; Schiavon O; Summerford C; Tirk A; Veronese FM; Vincenzi V; Wu G
Biomacromolecules; 2005; 6(2):914-26. PubMed ID: 15762660
[TBL] [Abstract][Full Text] [Related]
8. Amino acid sequence of a ferredoxin from Bumilleriopsis filiformis, a yellow-green alga: relationship with red algae, protoflorideophyceae, and filamentous blue-green algae.
Inoue K; Hase T; Böger P; Matsubara H
J Biochem; 1983 Nov; 94(5):1451-5. PubMed ID: 6418731
[TBL] [Abstract][Full Text] [Related]
9. Development of albumin-binding camptothecin prodrugs using a Peptide positional scanning library.
Schmid B; Warnecke A; Fichtner I; Jung M; Kratz F
Bioconjug Chem; 2007; 18(6):1786-99. PubMed ID: 17915955
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel delivery systems: the use of amino acid linkers in the conjugation of paclitaxel with carboxymethyldextran to create prodrugs.
Sugahara S; Kajiki M; Kuriyama H; Kobayashi TR
Biol Pharm Bull; 2002 May; 25(5):632-41. PubMed ID: 12033505
[TBL] [Abstract][Full Text] [Related]
11. Substrate specificity of cucumisin on synthetic peptides.
Yonezawa H; Kaizuka H; Uchikoba T; Arima K; Kaneda M
Biosci Biotechnol Biochem; 2000 Oct; 64(10):2104-8. PubMed ID: 11129582
[TBL] [Abstract][Full Text] [Related]
12. Improved in vivo antitumor efficacy and reduced systemic toxicity of carboxymethylpullulan-peptide-doxorubicin conjugates.
Nogusa H; Hamana H; Uchida N; Maekawa R; Yoshioka T
Jpn J Cancer Res; 2000 Dec; 91(12):1333-8. PubMed ID: 11123434
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of poly(ethylene glycol)-based saquinavir prodrug conjugates and assessment of release and anti-HIV-1 bioactivity using a novel protease inhibition assay.
Gunaseelan S; Debrah O; Wan L; Leibowitz MJ; Rabson AB; Stein S; Sinko PJ
Bioconjug Chem; 2004; 15(6):1322-33. PubMed ID: 15546199
[TBL] [Abstract][Full Text] [Related]
14. A new approach for the treatment of malignant melanoma: enhanced antitumor efficacy of an albumin-binding doxorubicin prodrug that is cleaved by matrix metalloproteinase 2.
Mansour AM; Drevs J; Esser N; Hamada FM; Badary OA; Unger C; Fichtner I; Kratz F
Cancer Res; 2003 Jul; 63(14):4062-6. PubMed ID: 12874007
[TBL] [Abstract][Full Text] [Related]
15. Albumin-binding prodrugs of camptothecin and doxorubicin with an Ala-Leu-Ala-Leu-linker that are cleaved by cathepsin B: synthesis and antitumor efficacy.
Schmid B; Chung DE; Warnecke A; Fichtner I; Kratz F
Bioconjug Chem; 2007; 18(3):702-16. PubMed ID: 17378599
[TBL] [Abstract][Full Text] [Related]
16. Relationship between drug release of DE-310, macromolecular prodrug of DX-8951f, and cathepsins activity in several tumors.
Shiose Y; Ochi Y; Kuga H; Yamashita F; Hashida M
Biol Pharm Bull; 2007 Dec; 30(12):2365-70. PubMed ID: 18057727
[TBL] [Abstract][Full Text] [Related]
17. Endothelin (ET)-1-induced inhibition of ATP release from PC-12 cells is mediated by the ETB receptor: differential response to ET-1 on ATP, neuropeptide Y, and dopamine levels.
Gardner A; Westfall TC; Macarthur H
J Pharmacol Exp Ther; 2005 Jun; 313(3):1109-17. PubMed ID: 15687374
[TBL] [Abstract][Full Text] [Related]
18. Peptide inhibitors for angiotensin I-converting enzyme from thermolysin digest of dried bonito.
Yokoyama K; Chiba H; Yoshikawa M
Biosci Biotechnol Biochem; 1992 Oct; 56(10):1541-5. PubMed ID: 1369054
[TBL] [Abstract][Full Text] [Related]
19. Determinants for the drug release from T-0128, camptothecin analogue-carboxymethyl dextran conjugate.
Harada M; Sakakibara H; Yano T; Suzuki T; Okuno S
J Control Release; 2000 Dec; 69(3):399-412. PubMed ID: 11102680
[TBL] [Abstract][Full Text] [Related]
20. Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy.
Pastorino F; Brignole C; Marimpietri D; Cilli M; Gambini C; Ribatti D; Longhi R; Allen TM; Corti A; Ponzoni M
Cancer Res; 2003 Nov; 63(21):7400-9. PubMed ID: 14612539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
